Eledon Pharmaceuticals Inc. buy Guggenheim
Start price
18.11.25
/
50%
€1.34
Target price
18.11.26
€6.90
Performance (%)
147.76%
Price
23.06.26
€3.22
Summary
This prediction is currently active. The BUY prediction by Guggenheim for Eledon Pharmaceuticals Inc. has seen massive gains of 147.76%. This prediction currently runs until 18.11.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Eledon Pharmaceuticals Inc. | 11.806% | 11.806% |
| iShares Core DAX® | 0.563% | 0.440% |
| iShares Nasdaq 100 | -0.162% | 1.619% |
| iShares Nikkei 225® | 1.098% | 9.607% |
| iShares S&P 500 | 0.014% | 0.689% |
Comments by Guggenheim for this prediction
In the thread Eledon Pharmaceuticals Inc. diskutieren
Eledon Pharmaceuticals (NASDAQ:ELDN) had its price target lowered by analysts at Guggenheim from $9.00 to $8.00. They now have a "buy" rating on the stock.
Ratings data for ELDN provided by MarketBeat
Stopped prediction by Guggenheim for Eledon Pharmaceuticals Inc.
Eledon Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€4.54
28.01.25
28.01.25
€8.63
28.01.26
28.01.26
-61.89%
29.01.26
29.01.26
